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Expression of the mouse renin genes (Renl and Ren2) in the submaxillary gland of female mice has been analyzed follow- 
ing administration of thyroxine (T4) or dihydrotestosterone (DHT). Both hormones appear to act independently on 
mRNA accumulation which increases about 5 fold over basal level. In vitro transcription assays in isolated nuclei demon- 
strate that both hormones act at the transcriptional level. The effects of DHT and T4 were also analyzed in transgenic 
mice obtained by microinjection of the Ren2 gene. We show that T4 is as efficient as DHT in promoting renin mRNA 
accumulation in these transgenic animals, in spite of their low basal level of Ren2 mRNA. Structural comparison of the 
Renl and Ren2 promoters with those of other genes regulated by T4 shows the conservation of two discrete regions. 
Hormonal regulation; Transgenic mouse; Thyroxine; Transcriptional regulation; (Submaxillary gland) 
1. INTRODUCTION 
The mouse renin genes are of particular interest 
for studying the hormonal control of gene expres- 
sion. Wild type and most laboratory mouse strains 
have two renin genes, Renl and Ren2 [l-3]. Ren2 
expression is at least two orders of magnitude 
higher than that of Renl in the SMG, while both 
genes are expressed at the same level in the kidney 
141. Moreover, these two genes encode 
distinguishable proteins [5]. Renin activity in the 
SMG is positively regulated by DHT and T4. These 
two hormones act independently of each other 
since SMG renin can be induced by T4 in Tfm/y 
mice which are resistant to DHT because they lack 
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functional androgen receptors [6]. The induced 
renin activity in the SMG after the hormonal treat- 
ment is correlated with a rapid increase in the level 
of its mRNA [7,8]. Whether this is the result of an 
enhanced rate of transcription or a stabilization of 
the mRNA remains to be established. 
Previous experiments on transgenic mice carry- 
ing an exogenous Ren2 gene showed that trans- 
genie males have levels of Ren2 mRNA 
comparable to that of Swiss male mice (two-renin 
gene strain). However, transgenic females have a 
very low level of renin mRNA when compared to 
Swiss females [9]. To determine whether basal level 
is controlled by thyroxine, we analyzed the ac- 
cumulation of the Ren2 mRNA in the SMG of 
transgenic mice in response to this hormone. 
We also show that DHT and T4 stimulate the 
transcription of the Ren2 gene and that the cis- 
responsive elements for both hormones are con- 
tained in the exogenous DNA fragment carried by 
transgenic mice. 
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2. MATERIALS AND METHODS 
2.1. Animals and hormone treatments 
Mouse strains were obtained from the Institut Pasteur and If- 
fa Credo. Transgenic mice were produced as described [9]. Mice 
used in all experiments were 8 weeks old. Thyroxine (Sigma) 
was dissolved in 10 mM NaOH and injected i.p. Mice were 
treated for 7 days with daily injections of 10 pg of T4 per 
animal. Testosterone induction was carried out by injection of 
12.5 mg of Sterandryl (Roussel). Animals were killed 1 week 
after hormone injection. For nuclear ‘run on’ assays, animals 
were injected i.p. with a single dose of 50 pg of T4 or 10 mg of 
Sterandryl and killed 2 h after the treatment. 
2.2. RNA analysis 
RNA was prepared from mouse tissues as previously de- 
scribed [9]. Northern blot experiments were performed as 
described [lo] using the renin cDNA [2] as probe. RNA dot-blot 
experiments were performed as described [l 11. 
2.3. In vitro transcription in isolated nuclei 
Nuclei isolation was performed essentially as described 
[12,13]. In vitro transcription was performed for 10 min at 
26°C in a 250 pl reaction mixture containing a 100 ,LLI aliquot of 
nuclei, 120 mM Tris-HCl, pH 8, 1.2 M KCl, 50 mM MgClz, 
RNasine (40 U), 2.5 mM GTP/ATP/UTP and 150&i of 
[(u-s*P]CTP (3000 Ci/mmol). Radiolabelled nuclear RNAs 
were purified as described [14] and hybridized to a 
nitrocellulose filter containing 4 pg of the renin cDNA; pUC18 
was used as negative control. Under these conditions, the 
amount of labelled transcripts that hybridize to the cloned 
cDNA will be proportional to the specific activity of that se- 
quence in the hybridization mixture. 
3. RESULTS 
3.1. Transcription of Ren2 gene in isolated nuclei 
To determine whether the accumulation of SMG 
renin mRNA after DHT and T4 treatment is due to 
an increased rate of transcription or to a post- 
transcriptional event, we carried out in vitro 
transcription assays in isolated nuclei extracted 
from the SMG of hormone-treated and untreated 
females. In the experiment shown in fig.1, four 
females received a single injection of either DHT 
(12.5 mg) or T4 (5Opg). Nuclei isolated from the 
SMG of female mice 2 h after administration of 
the hormone and nuclei isolated from the SMG of 
untreated females were brought to the same con- 
centration, then in vitro transcription was per- 
formed as described in section 2. The same amount 
of labelled RNA (10’ cpm) purified from SMG 
nuclei of hormone-treated and untreated females 
was hybridized onto replica filters containing the 
renin cDNA. The results of this analysis showed 
Fig.1. Induction of transcription in isolated nuclei of SMG 
renin mRNA by thyroxine and testosterone. 4pg plasmid 
containing the renin cDNA or pUC18 were spotted onto 
nitrocellulose filters as described in section 2. Equal counts of 
nascent-labelled nuclear RNA from SMG of T4-treated (Q T4), 
DHT-treated ( Q Te) or untreated females ( Q ) were hybridized 
to replicate filters. 
that females treated with DHT or T4 have higher 
levels of renin mRNA when compared to untreated 
controls (fig.1). DHT causes a 4-fold induction 
compared to 2-fold with T4 under these ex- 
perimental conditions. Plasmid pUC 18 was used as 
control DNA to monitor for non-specific binding 
of RNA. We conclude that the hormonal induction 
of the Ren2 gene is achieved mainly at a transcrip- 
tional level. 
SMG KIDNEY 
., 
-3’ 
o+ o+ 0 + o+ 
Ba I b/C C3H- BaiblC C3W 
Fig.2. Northern blot analysis of SMG and kidney poly(A)+ 
RNA extracted from normal and treated mice. 10 pg poly(A)+ 
RNA was electrophoresed through a 1 .l% agarose- 
formaldehyde gel, transferred to nitrocellulose and hybridized 
to the renin probe. Balb/C and CsH mice were treated with 
1Opg of thyroxine (+) daily as described in section 2. 
Untreated mice (0) of each strain were used as controls. 
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3.2. Stimulation of mRNA Renl accumulation by 3.3. Thyroxine treatment induces Ren2 mRNA 
thyroxine and testosterone accumulation in transgenic females 
To examine whether Renl is also regulated by 
DHT and T4 in the SMG, despite the different 
level of Renl mRNA accumulation in this tissue 
when compared to Ren2 mRNA, DHT and T4 
have been administered to females of two different 
mouse strains possessing only the Renl gene 
(Balb/C and C3H). 1Opg of poly(A+) RNA 
prepared from SMG, kidney and liver of control or 
treated females were analyzed by Northern blot 
hybridization, using the renin cDNA [2] as probe. 
The results presented in fig.2 show that, in the 
SMG, Renl mRNA accumulation increases about 
5- to lo-fold over basal level after T4 treatment. 
Similar results are obtained after administration of 
testosterone to females (not shown). Although 
these hormones are known to exert effects on 
various types of kidney cells, administration of 
DHT or T4 had no effect on the amount of Renl 
mRNA in the kidney (fig.2). Renin mRNA was not 
detected in the liver of mice following DHT or T4 
treatments (not shown). We conclude that these 
hormones increase the levels of Renl mRNA in a 
tissue-specific manner. 
Because thyroxine induction of endogenous 
renin mRNA is associated with an enhanced rate of 
renin gene transcription (see section 3.2), we have 
examined whether the exogenous Ren2 gene car- 
ried by transgenic female mice is induced after the 
administration of thyroxine. &week-old females of 
three transgenic lines were injected with T4, DHT 
or both hormones as described in section 2. Swiss 
females of the same age and subjected to the same 
hormonal treatment, were used as controls. Total 
RNA (1 lug) prepared from SMG of these animals 
was analyzed by Northern blot hybridization and 
renin mRNA accumulation was quantified by dot 
blot hybridization. Since the amount of renin 
mRNA found in the SMG of two-renin gene 
strains (like Swiss mice) is two orders of magnitude 
higher than in one-renin gene strains (like Balb/c), 
we used in these experiments amounts of RNA that 
allowed one to discriminate between renin 
transcripts coming from the endogenous Renl 
gene and the transgene Ren2. 
Fig.3 shows that T4 and DHT induce SMG renin 
mRNA to the same extent in transgenic females 
B 
Fig.3. Analysis of SMG renin mRNA extracted from normal and transgenic females in response to testosterone and thyroxine. (A) 
Northern blot of total RNA (1 pg) prepared from SMG of Swiss and transgenic female mice (Rn2-1). lanes: 1, males; 2, females; 
3, T4-treated females; 4, DHT and T4-treated females; 5, DHT-treated females. (B) Dot-blot analysis of hormone-treated transgenic 
females compared to Swiss female mice. Total SMG RNA of males (1), females (2), T4-treated females (3), DHT- and T4-treated 
females (4), DHT-treated females (5) were spotted onto nitrocellulose and hybridized to the renin probe. The amount of RNA spotted 
was 0.5 ,ug and subsequent serial dilutions were 1:4. 
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(Rn2-1) as in Swiss female mice. Similar results 
were obtained with the other two transgenic lines 
(not shown). Each hormone acts independently to 
stimulate Ren2 transcription. In both cases, the 
hormonal treatment increased renin mRNA in the 
SMG of female mice to a level equivalent to that 
of males. Because of the difference in basal levels, 
renin mRNA was increased around 20-fold in 
transgenic mice, versus 4-5-fold in normal two- 
gene strains. The finding that induction by DHT is 
more efficient than that with T4 was also observed 
in isolated SMG nuclei. 
4. DISCUSSION 
In vitro transcription assays on SMG nuclei pro- 
vide direct evidence that T4 and DHT induce the 
level of Ren2 mRNA by increasing the rate of Ren2 
transcription, the effect being observed as early as 
2 h after hormone administration. However, this 
does not in itself prove that the hormones act 
directly on the Ren2 gene. It is conceivable, though 
unlikely, that another protein is very rapidly in- 
duced and transcriptionally activates the Ren2 
gene. 
The results presented here have shown that ad- 
ministration of T4 or DHT increases the accumula- 
tion of Renl mRNA in the SMG of mice 
possessing only one renin gene. When an ex- 
ogenous Ren2 gene with its flanking regions is 
microinjected in fertilized mouse eggs carrying on- 
ly the Renl gene, the transgene is regulated by T4 
and DHT in the same manner as the Ren2 gene of 
wild type two-gene strains. Indeed, although the 
same renin probe is used to detect Renl or Ren2 
mRNA, the use of very low amounts of RNA 
allows one to distinguish between transcripts com- 
ing from the transgene (Ren2) or from the en- 
dogenous gene (Renl). Thus, transgenic female 
mice are sensitive to T4 induction suggesting that 
this hormone is not involved in the regulation of 
the renin basal level. The fact that Renl and Ren2 
expression is regulated by T4 and that thyroxine 
c&responsive elements are present in the DNA 
fragment carried by transgenic mice led us to com- 
pare the promoter sequences of the two renin genes 
with those of other T4 regulated genes. Most of the 
data concerning the identification of cis-acting 
elements which mediate T4 response have come 
from studies of rGH regulation. We compared the 
5 ‘-flanking region of the rGH gene to the 
5 ‘-flanking regions of the Renl and Ren2 genes. 
Two regions of striking similarity within two 
discrete T4 responsive lements described by Wight 
et al. [15] were found. The decanucleotide motif, 
TGGGTGGTCT, present in the gene coding for 
Table 1 
Presence of conserved motifs in the 5 ‘-flanking sequences of thyroxine responsive 
genes 
rGH TGGGTGGTCT GAAAACAGGTAG 
- 257 - 248 -45 -34 
Ren2 TGGGTGGTCT GAAAAGAGGTAG 
-675 - 666 -569 - 558 
Renl TGGGTGGTCT GAAAAGAGGTAG 
- 464 -455 - 351 - 346 
hGH TGGGTGGTAT GGAAAGGGATAG 
- 238 - 225 - 383 - 312 
Angiotensinogen GCGGTGCTCT CAAAACAGCGGC 
- 638 - 629 -613 - 602 
uNGF TTGGGGGTCA GCAAGCAGGAAG 
- 334 - 325 - 222 -210 
5 ‘-flanking regions of six thyroxine-responsive genes were compared for common 
sequence motifs. Genes compared are from rat growth hormone (rGH), mouse 
renin genes (Renl and Ren2), human growth hormone (hGH), angiotensinogen 
and the cu-subunit of mouse nerve growth factor ((uNGF). The positions relative 
to the principal transcriptional start point have been indicated 
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the rGH (positions - 248 to - 257 relative to the 
transcription start point [16]), and in the two 
mouse renin genes (positions -455 to -464 for 
Ren 1; - 666 to - 675 for Ren2 [17]). The second 
conserved element which is the dodecanucleotide 
GAAAACAGGTAG is found in the three genes 
with only one mismatch (the C is replaced by a G 
in the two renin genes). This motif is located at 
positions - 34 to - 45 for rGH; - 346 to - 357 for 
Renl and - 558 to - 569 for Ren2 (table 1). These 
two regions are also found in the gene coding for 
the hGH [18,19]. The genes for angiotensinogen 
and the a-subunit of the mouse nerve growth fac- 
tor are regulated by T4 [20-231 and contain two se- 
quences resembling those described above, 
although similarity does not exceed 70% for the 
first region and 75% for the second one. We are 
currently attempting to establish whether these se- 
quences in the two renin genes bind the thyroxine- 
receptor complex. 
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